Type III effector regulation of host signal transduction systems
宿主信号转导系统的 III 型效应器调节
基本信息
- 批准号:9010905
- 负责人:
- 金额:$ 44.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-08-11 至 2020-01-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAnti-Inflammatory AgentsAnti-inflammatoryAntibiotic ResistanceAntigensArchitectureAutoimmune DiseasesAutoimmunityBacterial InfectionsBacterial ModelBacterial ToxinsBacterial TypingBiochemicalBiochemistryBurkholderiaCaspaseCell physiologyCellsCellular StructuresCommunicable DiseasesComplexComputer AnalysisDataDisease ProgressionEngineeringEnvironmentEscherichia coliEscherichia coli EHECFamilyFoundationsGene FamilyGeneticGenetic ScreeningGenetic TranscriptionGenomicsGleanGoalsGuanine Nucleotide Exchange FactorsGuanine NucleotidesGuanosine Triphosphate PhosphohydrolasesHealthHistocompatibility TestingHumanHuman BiologyImmuneImmune responseImmunologic Deficiency SyndromesImmunologic ReceptorsInfectionInflammationInvestigationKnowledgeLeadLightLinkLipid ChemistryLipidsMalignant NeoplasmsMediatingMembraneMembrane LipidsMethionineMethodologyMicrobeModelingModificationMolecularMolecular MachinesMultienzyme ComplexesMutationNeedlesOrphanPathogenesisPathway interactionsPeptide HydrolasesPeptidesPhasePhosphatidylinositolsPhospholipidsPhysiologicalPlasmidsProcessPropertyProtein IsoformsProteinsProteomicsReceptor SignalingRegulationResearchResolutionRoleSalmonellaShigellaShigella InfectionsShigella flexneriSignal TransductionSiteSystemSystems BiologyTNF geneTNFRSF5 geneTestingTherapeutic InterventionTimeTissuesType III Secretion System PathwayUbiquitinVirulence FactorsWorkbasecombatdynamic systemfatty acylationimmune functioninnovationinsightmathematical modelmembermetastatic processmolecular dynamicsnew technologynew therapeutic targetnovelpathogenprogramsrhorho GTP-Binding Proteinssmall moleculetoolubiquitin-protein ligase
项目摘要
DESCRIPTION (provided by applicant): The type III secretion system of Gram-negative bacterial pathogens creates one of the most direct interfaces between pathogens and their hosts. These `needle-like' molecular machines inject bacterial effector proteins directly into host
cells for the purpose of destroying an innate immune response and facilitating bacterial replication, dissemination, and disease progression. Effector proteins are unique virulence factors in that they often capture or mimic the properties of host signal transduction molecules. The present study focuses on three important bacterial type III effector families. First, we will interrogate a large family of bacterial Guanine-nucleotide exchange factors (GEFs) required for Salmonella, Shigella, and enterohaemorrhagic E. coli pathogenesis, respectively, through their common ability to activate Rho-family GTPase signaling cascades. The studies described here will advance recent high-throughput genetic screening approaches to identify bacterial effector protein localization within the host cellular environment. Findings from these preliminary studies will be applied to uncover the system dynamics of host-pathogen interactions responsible for Shigella invasion, and particularly the role of host acidic phospholipids on bacterial GEF signaling functions (Aim 1). Second, we will characterize the novel enzymatic mechanism of the Invasion plasmid antigen J (IpaJ) family of bacterial cysteine proteases that catalyze the proteolytic elimination of N-myristoyl modifications on host ARF GTPase cellular substrates. Insights gleaned from these studies will be advanced through a detailed analysis of Shigella innate immune pathway evasion, and specifically the role of protein demyristoylation in this process (Aim 2). Finally, we will investigate orphan members of the Shigella E3-ubiquitin ligase superfamily, and specifically their ability to modulate host immune components through protein ubiquitylation (Aim 3). Developing new drugs that target bacterial and host enzyme complexes would be an innovative approach to combat emerging antibiotic resistant microbes. Therefore, by revealing molecular details of type III effector family functions, from biochemistry to systems biology, we will uncover sites of potential weakness in bacterial pathogens that may be exploited for therapeutic intervention. Importantly, these studies will also provide new insights into the pathogenic mechanisms of numerous infectious disease agents and also into the biology of the human host.
描述(由申请人提供):革兰氏阴性细菌病原体的III型分泌系统在病原体与其宿主之间形成最直接的界面之一。这些“针状”分子机器将细菌效应蛋白直接注入宿主
细胞,以破坏先天免疫应答并促进细菌复制、传播和疾病进展。效应蛋白是独特的毒力因子,因为它们经常捕获或模拟宿主信号转导分子的特性。本研究的重点是三个重要的细菌III型效应家族。首先,我们将询问沙门氏菌、志贺氏菌和肠出血性大肠杆菌所需的细菌鸟嘌呤核苷酸交换因子(GEFs)的大家族。大肠杆菌的致病性,分别通过其共同的能力,激活Rho家族GT3信号级联。这里描述的研究将推进最近的高通量遗传筛选方法,以确定宿主细胞环境中的细菌效应蛋白定位。这些初步研究的结果将被应用于揭示负责志贺氏菌入侵的宿主-病原体相互作用的系统动力学,特别是宿主酸性磷脂对细菌GEF信号传导功能的作用(目的1)。其次,我们将表征细菌半胱氨酸蛋白酶的侵入质粒抗原J(IpaJ)家族的新酶促机制,该家族催化宿主ARF GTdR细胞底物上的N-肉豆蔻酰修饰的蛋白水解消除。从这些研究中收集的见解将通过对志贺氏菌先天免疫途径逃避的详细分析,特别是蛋白质去豆蔻酰化在这一过程中的作用(目的2)。最后,我们将研究志贺氏菌E3-泛素连接酶超家族的孤儿成员,特别是他们通过蛋白质泛素化调节宿主免疫成分的能力(目的3)。开发针对细菌和宿主酶复合物的新药将是对抗新兴抗生素耐药微生物的创新方法。因此,通过揭示III型效应子家族功能的分子细节,从生物化学到系统生物学,我们将发现可能用于治疗干预的细菌病原体的潜在弱点。重要的是,这些研究还将为许多传染病病原体的致病机制以及人类宿主的生物学提供新的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Neal Mathew Alto其他文献
<em>Shigella</em> Puts the Brakes on the Host Cell Cycle
- DOI:
10.1016/j.chom.2007.08.003 - 发表时间:
2007-09-13 - 期刊:
- 影响因子:
- 作者:
Neal Mathew Alto - 通讯作者:
Neal Mathew Alto
Neal Mathew Alto的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Neal Mathew Alto', 18)}}的其他基金
Oxysterol Regulation of Microbial Pathogenesis
氧甾醇对微生物发病机制的调节
- 批准号:
10381602 - 财政年份:2021
- 资助金额:
$ 44.4万 - 项目类别:
Oxysterol Regulation of Microbial Pathogenesis
氧甾醇对微生物发病机制的调节
- 批准号:
10592354 - 财政年份:2021
- 资助金额:
$ 44.4万 - 项目类别:
Oxysterol Regulation of Microbial Pathogenesis
氧甾醇对微生物发病机制的调节
- 批准号:
10178988 - 财政年份:2021
- 资助金额:
$ 44.4万 - 项目类别:
Resolution of Inflammation by the SIX-family Transcription Factors
通过六家族转录因子解决炎症
- 批准号:
10328259 - 财政年份:2020
- 资助金额:
$ 44.4万 - 项目类别:
Resolution of Inflammation by the SIX-family Transcription Factors
通过六家族转录因子解决炎症
- 批准号:
10112827 - 财政年份:2020
- 资助金额:
$ 44.4万 - 项目类别:
Resolution of Inflammation by the SIX-family Transcription Factors
通过六家族转录因子解决炎症
- 批准号:
10553188 - 财政年份:2020
- 资助金额:
$ 44.4万 - 项目类别:
Bacterial Regulation of Eukaryotic Signaling Enzymes: Structure and Function
真核信号酶的细菌调节:结构和功能
- 批准号:
8235694 - 财政年份:2012
- 资助金额:
$ 44.4万 - 项目类别:
Bacterial Regulation of Eukaryotic Signaling Enzymes: Structure and Function
真核信号酶的细菌调节:结构和功能
- 批准号:
8788709 - 财政年份:2012
- 资助金额:
$ 44.4万 - 项目类别:
Bacterial Regulation of Eukaryotic Signaling Enzymes: Structure and Function
真核信号酶的细菌调节:结构和功能
- 批准号:
8415960 - 财政年份:2012
- 资助金额:
$ 44.4万 - 项目类别:
Bacterial Regulation of Eukaryotic Signaling Enzymes: Structure and Function
真核信号酶的细菌调节:结构和功能
- 批准号:
8603244 - 财政年份:2012
- 资助金额:
$ 44.4万 - 项目类别:
相似海外基金
Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
- 批准号:
10727507 - 财政年份:2023
- 资助金额:
$ 44.4万 - 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
- 批准号:
9194162 - 财政年份:2016
- 资助金额:
$ 44.4万 - 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
- 批准号:
496858-2016 - 财政年份:2016
- 资助金额:
$ 44.4万 - 项目类别:
University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
- 批准号:
9201955 - 财政年份:2015
- 资助金额:
$ 44.4万 - 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
- 批准号:
8251289 - 财政年份:2014
- 资助金额:
$ 44.4万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8302750 - 财政年份:2012
- 资助金额:
$ 44.4万 - 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
- 批准号:
267940 - 财政年份:2012
- 资助金额:
$ 44.4万 - 项目类别:
Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8403458 - 财政年份:2012
- 资助金额:
$ 44.4万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8472443 - 财政年份:2012
- 资助金额:
$ 44.4万 - 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8549297 - 财政年份:2012
- 资助金额:
$ 44.4万 - 项目类别: